S
Sushil K. Kashaw
Researcher at Central University, India
Publications - 119
Citations - 4038
Sushil K. Kashaw is an academic researcher from Central University, India. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 25, co-authored 102 publications receiving 3139 citations. Previous affiliations of Sushil K. Kashaw include Eugene Applebaum College of Pharmacy and Health Sciences & Dr. Hari Singh Gour University.
Papers
More filters
Journal ArticleDOI
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome.
Hashem O. Alsaab,Hashem O. Alsaab,Samaresh Sau,Rami Alzhrani,Rami Alzhrani,Katyayani Tatiparti,Ketki Bhise,Sushil K. Kashaw,Sushil K. Kashaw,Arun K. Iyer,Arun K. Iyer +10 more
TL;DR: The current landscape of the PD-1/PD-L1 mechanistic role in tumor immune evasion and therapeutic outcome for cancer treatment is reviewed and the current progress in clinical trials, combination of drug therapy with immunotherapy, safety, and future of check point inhibitors for multiple types of cancer are reviewed.
Journal ArticleDOI
Recent developments and biological activities of thiazolidinone derivatives: A review
TL;DR: This review aims to review the work reported on various biological activities of thiazolidinone derivatives from year 2000 to the beginning of 2011 and presents data for active compounds, some of which have passed the preclinical testing stage.
Journal ArticleDOI
siRNA Delivery Strategies: A Comprehensive Review of Recent Developments.
Katyayani Tatiparti,Samaresh Sau,Sushil K. Kashaw,Sushil K. Kashaw,Arun K. Iyer,Arun K. Iyer +5 more
TL;DR: This review presents a comprehensive update on the challenges of siRNA delivery and the current strategies used to develop nanoparticulate delivery systems.
Journal ArticleDOI
CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones
TL;DR: It can be concluded that synthesized compounds exhibited better sedative-hypnotic and CNS depressant activities than anticonvulsant activity.
Journal ArticleDOI
Synthesis and CNS depressant activity of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones.
TL;DR: From the experimental observation it can be concluded that synthesized compounds exhibited relatively better sedative-hypnotic and CNS depressant activities.